AFM13
Phase 2- Indications
- Hodgkin Lymphoma, CD30-positive lymphoma
Company intelligence / Profile preview
Hecht Healthcare Consulting provides strategic and operational consulting services to biopharmaceutical and life sciences companies. The company leverages the extensive industry experience of its founder, Dr. Thomas Hecht, who has held senior leadership roles in major biotech and pharma organizations.[1][4][5]
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hecht Healthcare Consulting.